Navigation Links
McGill partners with leading Swiss neuroscience research group
Date:10/4/2010

This release is available in French.

Building on its worldwide reputation as a leader in neuroscience research, McGill University today joined with two leading Swiss research institutions the University of Zurich (UZH) and the Swiss Federal Institute of Technology (ETHZ) to enhance neuroscience research in a host of areas, in fields that include pain therapy, Alzheimer's disease, synapse modelling and repair, neuroimmunology and genetic mechanisms of brain diseases.

The collaboration, backed by $200,000 in annual funding for three years, will see the institutions exchange scientists, develop research projects, establish fellowships for exchanges of graduate students, provide seed money for pilot studies and hold workshops into a variety of neuroscience research areas.

The two Swiss institutions form the Neuroscience Center of Zurich (ZNZ), which brings together 440 neuroscientists in clinical and basic science research. Established in 1998, the ZNZ is one of the first international programs of graduate studies of neuroscience in Europe.

"We are delighted to advance our cutting-edge neuroscience research through an international partnership with a leading network of neuroscience researchers," said McGill Principal and Vice-Chancellor Heather Munroe-Blum who, accompanied by Dr. Rmi Quirion, Vice-Dean (Science and Strategic Initiatives) in McGill's Faculty of Medicine, signed the memorandum of understanding in Switzerland. "Over the past years, McGill has developed significant agreements with a number of important centres of neuroscience research providing new impetus for advances in this crucial area of medical care.."

In the last 100 years Zurich scientists have contributed significantly to research on the nervous system, including work by such leaders in the field as Auguste Forel, Constantin von Monakow, Walter Rudolf Hess and Konrad Akert.

McGill's history as a leader in neuroscience research, from the legendary Wilder Penfield's establishment of the Montreal Neurological Institute and Hospital, is also widely known. Its pioneering contributions are exemplified by Penfield's maps of the sensory and motor cortices of the brain; Donald Hebb's hypothesis of activity-dependent synaptic plasticity; Brenda Milner's work on the mechanisms of memory; Juda Hirsch Quastel's studies in neurochemistry; Heinz Edgar Lehmann's pharmacological treatment of schizophrenia; Theodore Sourkes's proposal of dopamine replacement therapy in Parkinson's disease; Kris Krnejevic's work in chemical transmission; Ronald Melzack's "gate control" theory of pain and Albert Aguayo's demonstration of the potential capacity for re-growth of CNS axons, to name a few.

"This is a very exciting opportunity for us," Dr. Quirion said. "The Swiss neuroscience research centre is at the forefront of where we are headed in better understanding the brain and the central nervous system. Together with our interdisciplinary Brain@McGill program, we will have the opportunity to make significant advancements in research that will end up improving the lives of millions around the world."


'/>"/>

Contact: Doug Sweet
douglas.sweet@mcgill.ca
514-398-6752
McGill University
Source:Eurekalert

Related biology news :

1. McGill team discovers a piece of the puzzle for individualized cancer therapy via gene silencing
2. $1.7 million keeps McGill on edge
3. McGill plays important role in new global cancer-research network
4. McGill, Quebec biotech firm partner for new bone-disease treatment
5. Experts gather at McGill University to address food security challenges
6. McGill garners 19 Canada Research Chairs and more than $17 million in funding
7. McGill/JGH researchers successfully reverse multiple sclerosis in animals
8. McGill University receives almost $63 million under CFI program to support five research projects
9. 2 McGill researchers garner prestigious NSERC Steacie Fellowships
10. Peptides-on-demand: McGill researchers radical new green chemistry makes the impossible possible
11. Forget the antioxidants? McGill researchers cast doubt on role of free radicals in aging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology: